Advisors Capital Management LLC Acquires New Shares in CVS Health Corporation $CVS

Advisors Capital Management LLC bought a new stake in CVS Health Corporation (NYSE:CVS - Free Report) during the second quarter, according to its most recent filing with the Securities & Exchange Commission. The firm bought 268,386 shares of the pharmacy operator's stock, valued at approximately $27,765,000.

Other institutional investors have also modified their holdings of the company. Sei Investments Co. raised its stake in CVS Health by 17.4% during the 2nd quarter. Sei Investments Co. now owns 905,715 shares of the pharmacy operator's stock valued at $62,474,000 after acquiring an additional 134,535 shares in the last quarter. The Manufacturers Life Insurance Company increased its stake in CVS Health by 1.2% during the 2nd quarter. The Manufacturers Life Insurance Company now owns 1,121,377 shares of the pharmacy operator's stock valued at $77,353,000 after buying an additional 13,329 shares during the period. Treasurer of the State of North Carolina raised its position in shares of CVS Health by 1.3% during the 2nd quarter. Treasurer of the State of North Carolina now owns 585,073 shares of the pharmacy operator's stock worth $40,358,000 after buying an additional 7,588 shares in the last quarter. HUB Investment Partners LLC lifted its stake in shares of CVS Health by 25.0% in the 2nd quarter. HUB Investment Partners LLC now owns 15,063 shares of the pharmacy operator's stock worth $1,039,000 after acquiring an additional 3,011 shares during the period. Finally, Alliancebernstein L.P. boosted its holdings in shares of CVS Health by 8.0% in the second quarter. Alliancebernstein L.P. now owns 1,609,404 shares of the pharmacy operator's stock valued at $111,017,000 after acquiring an additional 119,439 shares in the last quarter. Institutional investors own 80.66% of the company's stock.

CVS Health Price Performance

NYSE CVS opened at $93.83 on Friday. The stock has a market capitalization of $120.01 billion, a P/E ratio of 24.82, a P/E/G ratio of 0.89 and a beta of 0.61. CVS Health Corporation has a 1 year low of $69.51 and a 1 year high of $110.68. The business's fifty day moving average is $102.19 and its two-hundred day moving average is $88.83. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.66 and a current ratio of 0.87.

CVS Health (NYSE:CVS - Get Free Report) last released its quarterly earnings data on Wednesday, August 5th. The pharmacy operator reported $2.58 earnings per share for the quarter, topping the consensus estimate of $1.87 by $0.71. The business had revenue of $106.10 billion during the quarter, compared to analyst estimates of $100.03 billion. CVS Health had a return on equity of 13.12% and a net margin of 1.18%.The company's revenue was up 7.3% compared to the same quarter last year. During the same period last year, the company posted $1.81 EPS. CVS Health has set its FY 2026 guidance at 7.900-8.100 EPS. On average, research analysts forecast that CVS Health Corporation will post 8.02 earnings per share for the current fiscal year.

CVS Health Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Monday, August 3rd. Investors of record on Thursday, July 23rd were given a $0.665 dividend. This represents a $2.66 annualized dividend and a dividend yield of 2.8%. The ex-dividend date was Thursday, July 23rd. CVS Health's dividend payout ratio is 70.37%.

Analyst Upgrades and Downgrades

A number of research analysts recently commented on CVS shares. Weiss Ratings upgraded shares of CVS Health from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Wednesday, August 5th. Truist Financial increased their price target on CVS Health from $108.00 to $118.00 and gave the company a "buy" rating in a research note on Tuesday, July 14th. Barclays lifted their price target on CVS Health from $106.00 to $108.00 and gave the company an "overweight" rating in a research report on Thursday, August 6th. HSBC restated a "hold" rating and issued a $103.00 price objective on shares of CVS Health in a report on Monday, July 6th. Finally, Cantor Fitzgerald raised their target price on CVS Health from $100.00 to $110.00 and gave the company an "overweight" rating in a research note on Tuesday, July 7th. Twenty-two research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $107.17.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.

Want to see what other hedge funds are holding CVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CVS Health Corporation (NYSE:CVS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source